HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsu, C.-P. Articles by Hsu, N.-Y. Search for Related Content PubMed PubMed Citation Articles by Hsu, C.-P. Articles by Hsu, N.-Y.

J Thorac Cardiovasc Surg 1995;110:374-381
© 1995 Mosby, Inc.

GENERAL THORACIC SURGERY

BRONCHIOLOALVEOLAR CARCINOMA

Taichung, Taiwan, Republic of China

From the Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China.

Received for publication Sept. 15, 1994. Accepted for publication Nov. 28, 1994. Address for reprints: Chung-Ping Hsu, MD, Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, #160, Sec 3, Taichung-Kang Rd., Taichung, Taiwan, Republic of China.

Abstract

Bronchioloalveolar carcinoma is a subtype of adenocarcinoma of the lung with a relatively better prognosis. We reviewed the cases of 50 consecutive patients with bronchioloalveolar carcinoma treated during a 10-year period and attempted to analyze factors related to prognosis. During the 10-year study period, the prevalence of bronchioloalveolar carcinoma relative to adenocarcinoma of the lung remained steady. The subjects included 32 male and 18 female patients with mean ages of 64.7 years and 55.1 years, respectively (p= 0.0030). The preoperative radiographic findings included 40 cases of localized and 10 cases of diffuse bronchioloalveolar carcinoma. The clinicopathologic TNM staging included 20 patients with stage I cancer, 4 with stage II cancer, 11 with stage IIIa cancer, 3 with stage IIIb cancer, and 12 with stage IV cancer. Forty patients with clinical stage I, II, or III disease underwent operation (operability 80%). The resectability rate was 90% (36 of 40). Thirty-four procedures were considered as curative. The overall cumulative survival at 5 years was 22.2% (46.4% for stage I). Different TNM stages showed significant differences in survival time (p= 0.0001). The median survival times were 64.6 months for stage I, 48.0 months for stage II, 24.7 months for stage IIIa, 9.0 months for stage IIIb, and 4.5 months for stage IV disease. The median survival time for localized bronchioloalveolar carcinoma was 27.5 months, and the median survival time for diffuse bronchioloalveolar carcinoma was 4.3 months (p= 0.0002). The median survival time for the curative resection group was 30.6 months, and the median survival time for the noncurative resection or nonresection group was 5.8 months (p= 0.0001). On the basis of this study we conclude that (1) the prevalence of bronchioloalveolar carcinoma is quite steady, (2) bronchioloalveolar carcinoma presents at an earlier age in women, (3) bronchioloalveolar carcinoma frequently presents with lymphatic spread or systemic metastasis at diagnosis, (4) most localized bronchioloalveolar carcinomas are resectable and the prognosis with this type is better than that of the diffuse type, and (5) long-term survival correlates closely with initial roentgenographic appearance, TNM stage, and completeness of surgical resection. (J THORACCARDIOVASCSURG1995;110:374-81)

This article has been cited by other articles:

				M. de Perrot, S. Chernenko, T. K. Waddell, Y. Shargall, A. F. Pierre, M. Hutcheon, and S. Keshavjee Role of Lung Transplantation in the Treatment of Bronchogenic Carcinomas for Patients With End-Stage Pulmonary Disease J. Clin. Oncol., November 1, 2004; 22(21): 4351 - 4356. [Abstract] [Full Text] [PDF]

				F. Barlesi, C. Doddoli, C. Gimenez, B. Chetaille, R. Giudicelli, P. Fuentes, J.-P. Kleisbauer, and P. Thomas Bronchioloalveolar carcinoma: myths and realities in the surgical management Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 159 - 164. [Abstract] [Full Text] [PDF]

				M. Wislez, M.-A. Massiani, B. Milleron, A. Souidi, M.-F. Carette, M. Antoine, and J. Cadranel Clinical Characteristics of Pneumonic-Type Adenocarcinoma of the Lung Chest, June 1, 2003; 123(6): 1868 - 1877. [Abstract] [Full Text] [PDF]

				O. Rena, E. Papalia, E. Ruffini, C. Casadio, P. L. Filosso, A. Oliaro, and G. Maggi Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 409 - 414. [Abstract] [Full Text] [PDF]

				G. L. Zorn Jr, D. C. McGiffin, K. R. Young Jr, C. B. Alexander, D. Weill, and J. K. Kirklin Pulmonary transplantation for advanced bronchioloalveolar carcinoma J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 45 - 48. [Abstract] [Full Text] [PDF]

				M. I. Ebright, M. F. Zakowski, J. Martin, E. S. Venkatraman, V. A. Miller, M. S. Bains, R. J. Downey, R. J. Korst, M. G. Kris, and V. W. Rusch Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma Ann. Thorac. Surg., November 1, 2002; 74(5): 1640 - 1647. [Abstract] [Full Text] [PDF]

				F. Barlesi, C. Doddoli, P. Thomas, J.-P. Kleisbauer, R. Giudicelli, and P. Fuentes Bilateral bronchioloalveolar lung carcinoma: is there a place for palliative pneumonectomy? Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1113 - 1116. [Abstract] [Full Text] [PDF]

				M. Palmarini and H. Fan Retrovirus-Induced Ovine Pulmonary Adenocarcinoma, an Animal Model for Lung Cancer J Natl Cancer Inst, November 7, 2001; 93(21): 1603 - 1614. [Abstract] [Full Text] [PDF]

				O. S. Breathnach, D. J. Kwiatkowski, D. M. Finkelstein, J. Godleski, D. J. Sugarbaker, B. E. Johnson, and S. Mentzer Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0042 - 47. [Abstract] [Full Text] [PDF]

				Y.-Y. Liu, Y.-M. Chen, M.-H. Huang, and R.-P. Perng Prognosis and Recurrent Patterns in Bronchioloalveolar Carcinoma Chest, October 1, 2000; 118(4): 940 - 947. [Abstract] [Full Text] [PDF]

				K. Okubo, E. J. Mark, D. Flieder, J. C. Wain, C. D. Wright, A. C. Moncure, H. C. Grillo, and D. J. Mathisen BRONCHOALVEOLAR CARCINOMA: CLINICAL, RADIOLOGIC, AND PATHOLOGIC FACTORS AND SURVIVAL J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 702 - 709. [Abstract] [Full Text] [PDF]

				S. Homma, M. Kawabata, K. Kishi, E. Tsuboi, K. Narui, T. Nakatani, and K. Nakata Successful Treatment of Refractory Bronchorrhea by Inhaled Indomethacin in Two Patients With Bronchioloalveolar Carcinoma Chest, May 1, 1999; 115(5): 1465 - 1468. [Abstract] [Full Text] [PDF]

				A. C. White and E. J. Mark Case 40-1996- A 58-Year-Old Man with Progressive Hypotension and Respiratory Failure after Treatment for Apparent Pulmonary Tuberculosis N. Engl. J. Med., December 26, 1996; 335(26): 1974 - 1982. [Full Text] [PDF]